Home LiteratureArticle Details
PMID: 1985000 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections.

Digestive diseases and sciences ·Vol. 36 ·No. 1 ·1991-01-00 ·Pages 25-8

Westblom TU, Duriex DE

Abstract

We measured the effects of cimetidine on antibiotic concentrations in the luminal portion of gastric mucosa. Guinea pigs were premedicated with cimetidine 4 mg/kg intramuscularly. Clindamycin, an antibiotic previously characterized under physiologic pH conditions, was administered intramuscularly and levels measured in serum and tissue using a high-pressure liquid chromatography (HPLC) technique. The luminal mucosa concentration of clindamycin at 1 hr (pH 5.9) was fivefold greater compared to the concentrations seen under physiologic (pH 2.0) conditions (81.5 micrograms/g vs 15.9 micrograms/g; P less than 0.05) and 10-fold greater at 2 hr (82.7 micrograms/g vs 8.09 micrograms/g; P less than 0.05). There was no difference in peak serum levels between the groups. The finding that an antibiotic with characteristics of a base is thus affected by a nonconservative acid inhibitor such as cimetidine supports the presence of an acidic storage pool as proposed by other investigators. H2-receptor antagonists may be useful therapeutic adjuncts in H. pylori infections by virtue of increasing gastric concentrations of antibiotics that behave as weak bases.

MeSH Terms
Acid-Base Equilibrium/drug effects Animals Chromatography, High Pressure Liquid Cimetidine/pharmacology Clindamycin/pharmacokinetics,therapeutic use Gastric Mucosa/drug effects,metabolism Guinea Pigs Helicobacter Infections/drug therapy Helicobacter pylori/drug effects
Chemicals
Clindamycin Cimetidine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Westblom T U
Department of Medicine, St. Louis University, Missouri.
Duriex D E
References (21)
21 references, click to expand
  1. Cellular site of gastric acid secretion.
    Proc Natl Acad Sci U S A. 1979 Dec;76(12):6689-93 PMID: 42918
  2. Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.
    Antimicrob Agents Chemother. 1990 Jan;34(1):25-8 PMID: 2327758
  3. Invariant relation between total acid secretion and secretagogue exposure: secretory dynamics in bullfrog.
    Am J Physiol. 1984 Apr;246(4 Pt 1):G325-30 PMID: 6609645
  4. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.
    Scand J Gastroenterol Suppl. 1989;167:49-54 PMID: 2617169
  5. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.
    Med J Aust. 1989 Oct 16;151(8):431-5 PMID: 2687668
  6. Chronic gastritis--a pathogenetic approach.
    J Pathol. 1988 Feb;154(2):113-24 PMID: 3280764
  7. Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept.
    Lancet. 1988 Dec 24-31;2(8626-8627):1467-9 PMID: 2904580
  8. Omeprazole: inhibitor of both acid formation and translocation in gastric mucosa.
    Acta Physiol Scand. 1989 Oct;137(2):223-30 PMID: 2618761
  9. Thiocyanate and nitrite inhibit proton translocation in gastric mucosa.
    Biochim Biophys Acta. 1985 Jul 11;817(1):147-53 PMID: 2988618
  10. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium.
    J Infect Dis. 1986 Apr;153(4):658-63 PMID: 3950447
  11. Treatment failure of ofloxacin in Campylobacter pylori infection.
    Lancet. 1987 May 9;1(8541):1096 PMID: 2883434
  12. Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function.
    J Antimicrob Chemother. 1983 Oct;12 Suppl C:39-50 PMID: 6315671
  13. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection.
    Gastroenterol Clin Biol. 1989;13(1 Pt 1):96B-100B PMID: 2663605
  14. Campylobacter pylori--therapy review.
    Scand J Gastroenterol Suppl. 1989;160:35-8 PMID: 2683022
  15. Clindamycin secretion across human gastric mucosa.
    J Clin Gastroenterol. 1989 Oct;11(5):601-2 PMID: 2794449
  16. Accumulation of weak base in gastric mucosa provides evidence for an acidic storage compartment.
    Am J Physiol. 1989 Nov;257(5 Pt 1):G836-44 PMID: 2596614
  17. Conservative and nonconservative inhibitors of gastric acid secretion.
    Am J Physiol. 1987 Sep;253(3 Pt 1):G359-68 PMID: 3115114
  18. K+ and Cl- conductances in the apical membrane from secreting oxyntic cells are concurrently inhibited by divalent cations.
    J Membr Biol. 1985;83(3):261-72 PMID: 2582127
  19. Gastric metaplasia in the duodenum and Campylobacter pylori.
    Gastroenterol Clin Biol. 1989;13(1 Pt 1):78B-82B PMID: 2663602
  20. The physiology of gastric acid secretion.
    N Engl J Med. 1988 Dec 29;319(26):1707-15 PMID: 3060722
  21. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa.
    J Antimicrob Chemother. 1988 Nov;22(5):729-38 PMID: 3209531
Article Info
Journal
Digestive diseases and sciences
Abbr.
Dig Dis Sci
ISSN
0163-2116
Published
1991-01-00
Pages
25-8
Language
English
Region
United States
NLM ID
7902782
Subset
IM
Grants
NCRR NIH HHS · RR05870 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]